0001209191-17-030119.txt : 20170504 0001209191-17-030119.hdr.sgml : 20170504 20170504180210 ACCESSION NUMBER: 0001209191-17-030119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170503 FILED AS OF DATE: 20170504 DATE AS OF CHANGE: 20170504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Pharma plc CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272179987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANTINI GINO CENTRAL INDEX KEY: 0001276038 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 17815520 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-03 0 0001492426 Horizon Pharma plc HZNP 0001276038 SANTINI GINO C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 1 0 0 0 Ordinary Shares 2017-05-03 4 M 0 13953 A 17793 I By Trust Ordinary Shares 2017-05-03 4 F 0 5477 15.12 D 12316 I By Trust Restricted Stock Units 2017-05-03 4 M 0 13953 0.00 D Ordinary shares 13953 0 D Stock Option (Right to Buy) 15.12 2017-05-03 4 A 0 31153 0.00 A 2027-05-02 Ordinary shares 31153 31153 D Restricted Stock Units 2017-05-03 4 A 0 14054 0.00 A 2018-05-03 Ordinary shares 14054 14054 D Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date. The option vests in 12 equal monthly installments from the date of grant. /s/ Paul W. Hoelscher, Attorney-in-Fact 2017-05-04